Aortic Complications Associated With Pregnancy in Marfan Syndrome: The NHLBI National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC)

Background The risk of aortic complications associated with pregnancy in women with Marfan syndrome (MFS) is not fully understood. Methods and Results MFS women participating in the large National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) were evaluated. Among 184 women with MFS in whom pregnancy information was available, 94 (51%) had a total of 227 pregnancies. Among the women with pregnancies, 10 (10.6%) experienced a pregnancy‐related aortic complication (4 type A and 3 type B dissections, 1 coronary artery dissection, and 2 with significant [≥3 mm] aortic growth). Five of 7 aortic dissections, including all 3 type B, and the coronary dissection (75% of all dissections) occurred in the postpartum period. Only 5 of 8 women with pregnancy‐associated dissection were aware of their MFS diagnosis. The rate of aortic dissection was higher during the pregnancy and postpartum period (5.4 per 100 person‐years vs 0.6 per 100 person‐years of nonpregnancy; rate ratio, 8.4 [95% CI=3.9, 18.4]; P<0.0001). Conclusions Pregnancy in MFS is associated with an increased risk of aortic dissection, both types A and B, particularly in the immediate postpartum period. Lack of knowledge of underlying MFS diagnosis before aortic dissection is a major contributing factor. These findings underscore the need for early diagnosis, prepregnancy risk counseling, and multidisciplinary peripartum management.

[1]  R. Austin,et al.  MARFAN SYNDROME , 2018, Cassidy and Allanson's Management of Genetic Syndromes.

[2]  L. Swan,et al.  Marfan syndrome and pregnancy: maternal and neonatal outcomes , 2014, BJOG : an international journal of obstetrics and gynaecology.

[3]  R. De Palma,et al.  Acute aortic dissection: epidemiology and outcomes. , 2013, International journal of cardiology.

[4]  D. Luton,et al.  Pregnancy outcomes among women with Marfan syndrome , 2013, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[5]  Amitava Banerjee,et al.  Population-Based Study of Incidence and Outcome of Acute Aortic Dissection and Premorbid Risk Factor Control: 10-Year Results From the Oxford Vascular Study , 2013, Circulation.

[6]  M. Czerny,et al.  Acute Aortic Dissection Determines the Fate of Initially Untreated Aortic Segments in Marfan Syndrome , 2013, Circulation.

[7]  A. Yetman,et al.  The immediate and long-term impact of pregnancy on aortic growth rate and mortality in women with Marfan syndrome. , 2012, Journal of the American College of Cardiology.

[8]  Mike Kirby,et al.  ESC Guidelines on the Management of Cardiovascular Diseases During Pregnancy , 2012 .

[9]  Mike Kirby,et al.  Guidelines on the management of cardiovascular diseases during pregnancy The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology ( ESC ) , 2011 .

[10]  Howard K. Song,et al.  The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC): results from phase I and scientific opportunities in phase II. , 2011, American heart journal.

[11]  G. Jondeau,et al.  Dissection in Marfan syndrome: the importance of the descending aorta. , 2011, European heart journal.

[12]  Laurence Faivre,et al.  The revised Ghent nosology for the Marfan syndrome , 2010, Journal of Medical Genetics.

[13]  David M. Williams,et al.  2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, Ame , 2010, Journal of the American College of Cardiology.

[14]  G. Jondeau,et al.  Maternal complication of pregnancy in Marfan syndrome. , 2009, International journal of cardiology.

[15]  K. Eagle.  Rationale and design of the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC). , 2009, American heart journal.

[16]  Christoph U. Lehmann,et al.  Progressive dilation of the ascending aorta in children with isolated bicuspid aortic valve. , 2007, The American journal of cardiology.

[17]  D. Judge,et al.  Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states , 2007, Nature Medicine.

[18]  H. Dietz,et al.  Perturbations of Vascular Homeostasis and Aortic Valve Abnormalities in Fibulin-4 Deficient Mice , 2007, Circulation research.

[19]  G. Jondeau,et al.  Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome. , 2007, The American journal of cardiology.

[20]  P. Byers,et al.  Aneurysm syndromes caused by mutations in the TGF-beta receptor. , 2006, The New England journal of medicine.

[21]  David D. Shin,et al.  Approach to the patient with bicuspid aortic valve and ascending aorta aneurysm , 2006, Current treatment options in cardiovascular medicine.

[22]  M. Nieminen,et al.  Abstract 2995: Impact of Atenolol versus Losartan-Based Treatment on Aortic Root Dilatation in Hypertension: The LIFE Study , 2006 .

[23]  D. Resnik,et al.  Protecting third parties in human subjects research. , 2006, IRB.

[24]  Marc K. Halushka,et al.  Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.

[25]  H. Dietz,et al.  Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome , 2006, Nature Genetics.

[26]  K. Berecek,et al.  Thrombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions. , 2006, Biochemical and biophysical research communications.

[27]  Wolfram Kress,et al.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.

[28]  G. Boers,et al.  Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. , 2005, European heart journal.

[29]  S. Shete,et al.  Mutations in Transforming Growth Factor-&bgr; Receptor Type II Cause Familial Thoracic Aortic Aneurysms and Dissections , 2005, Circulation.

[30]  M. Borger,et al.  Management of the valve and ascending aorta in adults with bicuspid aortic valve disease. , 2005, Seminars in thoracic and cardiovascular surgery.

[31]  D. Milewicz,et al.  Treatment of aortic disease in patients with Marfan syndrome. , 2005, Circulation.

[32]  水口 剛.  Heterozygous TGFBR2 mutations in Marfan syndrome , 2005 .

[33]  C. Nienaber,et al.  Stent-Grafts in Patients with Marfan Syndrome , 2005, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[34]  T. Sundt,et al.  Surgery for Aneurysms of the Aortic Root: A 30-Year Experience , 2004, Circulation.

[35]  J. Lima,et al.  Results of aortic valve-sparing operations: experience with remodeling and reimplantation procedures in 65 patients. , 2004, The Annals of thoracic surgery.

[36]  H. Safi,et al.  Aortic dissection , 2004, The British journal of surgery.

[37]  L. Melton,et al.  Acute aortic dissection: population-based incidence compared with degenerative aortic aneurysm rupture. , 2004, Mayo Clinic proceedings.

[38]  J. Rahman,et al.  Obstetric and gynecologic complications in women with Marfan syndrome. , 2003, The Journal of reproductive medicine.

[39]  D. Milewicz,et al.  Genetic basis of thoracic aortic aneurysms and dissections , 2002, Current opinion in cardiology.

[40]  G. Collod-Béroud,et al.  Marfan syndrome in the third Millennium , 2002, European Journal of Human Genetics.

[41]  K. Eagle,et al.  Choice of computed tomography, transesophageal echocardiography, magnetic resonance imaging, and aortography in acute aortic dissection: International Registry of Acute Aortic Dissection (IRAD). , 2002, The American journal of cardiology.

[42]  V. Gott,et al.  Aortic root replacement in 271 Marfan patients: a 24-year experience. , 2002, The Annals of thoracic surgery.

[43]  K. Eagle,et al.  Predicting Death in Patients With Acute Type A Aortic Dissection , 2002, Circulation.

[44]  H. Wallenburg,et al.  The Marfan syndrome and pregnancy: a retrospective study in a Dutch population. , 2001, European journal of obstetrics, gynecology, and reproductive biology.

[45]  E. Boerwinkle,et al.  Familial Thoracic Aortic Aneurysms and Dissections: Genetic Heterogeneity With a Major Locus Mapping to 5q13-14 , 2001, Circulation.

[46]  D. Milewicz,et al.  Identification of a Chromosome 11q23.2-q24 Locus for Familial Aortic Aneurysm Disease, a Genetically Heterogeneous Disorder , 2001, Circulation.

[47]  J. Botkin,et al.  Protecting the privacy of family members in survey and pedigree research. , 2001, JAMA.

[48]  C. Bodian,et al.  Results of Immediate Surgical Treatment of All Acute Type A Dissections , 2000, Circulation.

[49]  T. Kohmoto,et al.  Ruptured aortic dissecting aneurysm in Turner's syndrome: a case report and review of literature. , 2000, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[50]  P. Van der Niepen,et al.  Aortic dissection and Turner's syndrome. , 2000, The Journal of cardiovascular surgery.

[51]  M. Underwood,et al.  The aortic root: structure, function, and surgical reconstruction , 2000, Heart.

[52]  C. Junien,et al.  Demonstration of the recurrence of Marfan-like skeletal and cardiovascular manifestations due to germline mosaicism for an FBN1 mutation. , 1999, American Journal of Human Genetics.

[53]  A. Mazzucco,et al.  Recurrence of aortic insufficiency after aortic root remodeling with valve preservation. , 1999, The Annals of thoracic surgery.

[54]  M. Roman,et al.  Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome. , 1999, The American journal of cardiology.

[55]  L. Peltonen,et al.  Recurrence of Marfan syndrome as a result of parental germ-line mosaicism for an FBN1 mutation. , 1999, American journal of human genetics.

[56]  J. Sowers,et al.  Diabetes and cardiovascular disease. , 1999, Diabetes care.

[57]  C. Nienaber,et al.  Aneurysms of the ascending aorta: Diagnostic features and prognosis in patients with marfan's syndrome versus hypertension , 1998, Clinical cardiology.

[58]  D. Milewicz,et al.  Reduced penetrance and variable expressivity of familial thoracic aortic aneurysms/dissections. , 1998, The American journal of cardiology.

[59]  E E van der Wall,et al.  Marfan syndrome in children and adolescents: predictive and prognostic value of aortic root growth for screening for aortic complications , 1998, Heart.

[60]  A. Lin,et al.  Further Delineation of Aortic Dilation, Dissection, and Rupture in Patients With Turner Syndrome , 1998, Pediatrics.

[61]  R E Fromm,et al.  Acute thoracic aortic dissection: the basics. , 1997, The Journal of emergency medicine.

[62]  Karen J. Lipscomb,et al.  Outcome of pregnancy in women with Marfan's syndrome , 1997, British journal of obstetrics and gynaecology.

[63]  J. Repke,et al.  A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. , 1995, American journal of obstetrics and gynecology.

[64]  U. Francke,et al.  Fibrillin abnormalities and prognosis in Marfan syndrome and related disorders. , 1995, American journal of medical genetics.

[65]  U. Francke,et al.  A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection. , 1995, American journal of human genetics.

[66]  N. Kouchoukos,et al.  Life expectancy in the Marfan syndrome. , 1995, The American journal of cardiology.

[67]  R. Jeremy,et al.  Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome. , 1994, The American journal of cardiology.

[68]  E. Murphy,et al.  Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. , 1994, The New England journal of medicine.

[69]  R. Boxer,et al.  Peripartum acute myocardial infarction in Marfan's syndrome. , 1994, American Heart Journal.

[70]  R. Jeremy,et al.  The natural history of aortic dilatation in Marfan syndrome , 1993, The Medical journal of Australia.

[71]  M. Yacoub,et al.  Remodeling of the aortic valve anulus. , 1993, The Journal of thoracic and cardiovascular surgery.

[72]  E. Puffenberger,et al.  Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene. , 1992, The Journal of clinical investigation.

[73]  T. David,et al.  An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. , 1992, The Journal of thoracic and cardiovascular surgery.

[74]  Ada Hamosh,et al.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene , 1991, Nature.

[75]  R. Glanville,et al.  Partial sequence of a candidate gene for the Marfan syndrome , 1991, Nature.

[76]  R. Pyeritz,et al.  The Marfan syndrome in early childhood: analysis of 15 patients diagnosed at less than 4 years of age. , 1983, The American journal of cardiology.

[77]  N. Rosenblum,et al.  Failure of serial echocardiographic studies to predict aortic dissection in a pregnant patient with Marfan's syndrome. , 1983, American journal of obstetrics and gynecology.

[78]  R. Pyeritz.  Maternal and fetal complications of pregnancy in the Marfan syndrome. , 1981, The American journal of medicine.

[79]  M. Pawlaczyk,et al.  [Marfan's syndrome in pregnancy]. , 1981, Ginekologia Polska.

[80]  A. Fazekas,et al.  [Marfan syndrome and pregnancy]. , 1979, Orvosi hetilap.

[81]  O. Piiroinen,et al.  Marfan Syndrome, Pregnancy, and Fatal Dissection of Aorta , 1971, Acta obstetricia et gynecologica Scandinavica.

[82]  L. Freidman,et al.  Aortic dissection in pregnancy: a case of Marfan's syndrome. , 1958, American heart journal.

[83]  J. Elefteriades.  Perspectives on diseases of the thoracic aorta. , 2004, Advances in cardiology.

[84]  R. Akhurst.  TGF beta signaling in health and disease. , 2004, Nature genetics.

[85]  D. Arking,et al.  Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. , 2003, Nature genetics.

[86]  P. Costello,et al.  The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. , 1993, The New England journal of medicine.

[87]  T. Kurczynski,et al.  Marfanoid children. Etiologic heterogeneity and cardiac findings. , 1991, American journal of diseases of children.

[88]  Eter,et al.  CLINICAL AND GENETIC FEATURES OF EHLERS – DANLOS SYNDROME TYPE IV , THE VASCULAR TYPE , 2022 .